CD22 Antibody / BL-CAM

CD22 is primarily expressed on mature B cells and plays a role in B cell survival, adhesion, and migration within lymphoid tissues. Altered CD22 expression or function has been associated with autoimmune diseases and B cell malignancies, making it an important biomarker and therapeutic target in immunology and oncology research. Using a high-quality CD22 antibody enables sensitive detection in applications such as flow cytometry, immunohistochemistry, and western blot. A CD22 antibody from NSJ Bioreagents ensures reproducibility and accuracy for studies in B cell biology, immune regulation, and cancer research. Selecting the right CD22 antibody is critical for generating consistent and reliable experimental results.